Cedar Hill Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $5.34M | Sell |
23,855
-13,538
| -36% | -$3.03M | 2.05% | 15 |
|
|
2018
Q3 | $9.13M | Sell |
37,393
-3,788
| -9% | -$924K | 2.05% | 14 |
|
|
2018
Q2 | $8.53M | Sell |
41,181
-5,735
| -12% | -$1.19M | 1.77% | 17 |
|
|
2018
Q1 | $9.69M | Sell |
46,916
-9,164
| -16% | -$1.89M | 1.92% | 14 |
|
|
2017
Q4 | $10.6M | Sell |
56,080
-4,304
| -7% | -$817K | 1.85% | 19 |
|
|
2017
Q3 | $11.4M | Sell |
60,384
-4,805
| -7% | -$909K | 1.97% | 19 |
|
|
2017
Q2 | $11.4M | Sell |
65,189
-5,334
| -8% | -$931K | 2.36% | 15 |
|
|
2017
Q1 | $10.8M | Sell |
70,523
-24,650
| -26% | -$3.79M | 2.26% | 21 |
|
|
2016
Q4 | $13.4M | Sell |
95,173
-1,008
| -1% | -$142K | 2.26% | 20 |
|
|
2016
Q3 | $15.3M | Sell |
96,181
-126
| -0.1% | -$20K | 2.5% | 16 |
|
|
2016
Q2 | $14.2M | Sell |
96,307
-45,020
| -32% | -$6.65M | 2.44% | 19 |
|
|
2016
Q1 | $20M | Buy |
141,327
+1,640
| +1% | +$232K | 3.48% | 2 |
|
|
2015
Q4 | $19.8M | Sell |
139,687
-1,290
| -0.9% | -$183K | 3.48% | 3 |
|
|
2015
Q3 | $17.2M | Buy |
140,977
+19,548
| +16% | +$2.39M | 3.06% | 6 |
|
|
2015
Q2 | $15.8M | Buy |
121,429
+615
| +0.5% | +$79.8K | 2.48% | 7 |
|
|
2015
Q1 | $16.2M | Buy |
120,814
+1,609
| +1% | +$216K | 2.58% | 7 |
|
|
2014
Q4 | $14.9M | Buy |
119,205
+6,745
| +6% | +$845K | 2.36% | 7 |
|
|
2014
Q3 | $13.7M | Buy |
112,460
+1,838
| +2% | +$224K | 2.21% | 9 |
|
|
2014
Q2 | $13.1M | Buy |
110,622
+7,700
| +7% | +$909K | 2.06% | 12 |
|
|
2014
Q1 | $12.4M | Sell |
102,922
-4,126
| -4% | -$496K | 2.08% | 14 |
|
|
2013
Q4 | $11.9M | Sell |
107,048
-4,324
| -4% | -$481K | 2.12% | 13 |
|
|
2013
Q3 | $10.3M | Sell |
111,372
-6,146
| -5% | -$566K | 1.95% | 13 |
|
|
2013
Q2 | $9.95M | Buy |
+117,518
| New | +$9.95M | 1.95% | 14 |
|